Table 4 Sick listing in women before, during and after intervention
18-months before project start March, 2016 | 18-months before project end Aug, 2017 | Project start Sept, 2017 | 3-month follow-up Dec, 2017 | 6-month follow-up March, 2018 | 12-month follow-up Sept, 2018 | Project end Feb, 2019 | |
|---|---|---|---|---|---|---|---|
Total number of people on sick leave (women % (n/n)) | 125/200 (63%) | 119/181 (66%) | 136/204 (67%) | 127/186 (68%) | 136/194 (70%) | 129/191 (68%) | 130/191 (68) |
Sick leave duration (women % (n/n)) | |||||||
1 – 90 days | 49/80 (61%) | 50/81 (62%) | 70/103 (68%) | 55/82 (67%) | 68/100 (68%) | 56/83 (67%) | 60/91 (66%) |
91—180 days | 21/34 (62%) | 14/19 (74%) | 11/18 (61%) | 22/29 (76%) | 16/20 (80%) | 20/30 (67%) | 18/28 (64%) |
181—365 days | 23/34 (68%) | 21/29 (72%) | 18/27 (67%) | 15/21 (74%) | 18/26 (69%) | 16/29 (55%) | 18/28 (64%) |
> 365 days | 32/52 (62%) | 34/52 (65%) | 37/56 (66%) | 35/54 (65%) | 34/48 (71%) | 37/49 (76%) | 34/44 (77%) |
Sick leave grade women % (n/n) | |||||||
25% | 14/17 (82%) | 9/14 (64%) | 8/12 (67%) | 12/17 (71%) | 6/12 (50%) | 13/17 (76%) | 18/23 (78%) |
50% | 33/44(75%) | 14/25 (56%) | 16/32 (50%) | 20/33 (61%) | 21/31 (68%) | 22/33 (67%) | 15/27 (56%) |
75% | 9/13 (69%) | 6/9 (67%) | 5/6 (83%) | 6/6 (100%) | 4/4 (100%) | 10/12 (83%) | 9/13 (69%) |
100% | 69/126 (55%) | 90/133 (68%) | 107/154 (69%) | 89/130 (72%) | 105/147 (71%) | 84/129 (65%) | 88/128 (69%) |